Wise Medical (688580.SH) Highlights Extensive Product Portfolio and Technological Reserves in Non-Invasive Brain-Computer Interface Field in IPO Prospectus

Gelonghui September 10th丨VISHEE(688580.SH)Stated on the investor interaction platform,VISHEE has a wealth of products and technical reserves in the field of non-invasive brain-computer interface, covering group biofeedback, multi-parameter biofeedback, neonatal EEG monitoring and other products. To date, the company has obtained dozens of patent achievements related to brain-computer interfaces, involving core technologies such as EEG signal acquisition, EEG interference signal correction, signal transmission analysis, and machine learning algorithms. At the same time, it has also accumulated multiple patents and technical reserves in non-invasive brain-computer interface electrodes. Meanwhile, the company's current technology layout in the field of neurorehabilitation has expanded from single devices to full-cycle solutions covering "diagnosis-treatment-rehabilitation." Regarding closed-loop neurorehabilitation systems, the company already possesses capabilities in EEG acquisition, non-invasive neuromodulation, and rehabilitation.RobotTechnologies such as these, based on actual clinical needs, can achieve a closed-loop rehabilitation chain of "brain signal acquisition-intention interpretation-magnetic stimulation regulation-mechanical assistance execution": ① For stroke sequelae patients, motion imagination signals can be captured in real time through EEG caps, synchronously triggering rehabilitation robots to perform training. Meanwhile, transcranial magnetic stimulation (TMS) can enhance neural plasticity and accelerate motor function reconstruction; ② For spinal cord injury patients, the company's surface electromyography analysis system can evaluate residual nerve function, combined with pulsed magnetic field therapy devices to intervene in damaged spinal segments, forming personalized rehabilitation plans. Relying on the support of national macro policies, the company will closely monitor the development and application of cutting-edge technologies in neuroscience, actively explore and carry out various forms of business and technical cooperation, jointly promoting the leapfrog development of the rehabilitation medicine field from traditional models to precision and intelligent ones.